Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial (Q35419840)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial |
scientific article |
Statements
1 reference
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial (English)
1 reference
Eleftherios P Mamounas
Katherine L Pogue-Geile
Nan Song
Seong-Rim Kim
Nicole L Blackmon
Melanie Finnigan
Priya Rastogi
Louis Fehrenbacher
D Lawrence Wickerham
Charles E Geyer
Joseph P Costantino
Norman Wolmark
5 January 2015
1 reference